- Report
- February 2026
- 195 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- December 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- December 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- June 2026
- 52 Pages
Global
From €6815EUR$7,500USD£5,857GBP
- Report
- May 2026
- 130 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- October 2025
- 95 Pages
Global
From €4089EUR$4,500USD£3,514GBP
- Report
- April 2026
- 200 Pages
United States
From €2717EUR$2,990USD£2,335GBP
- Report
- June 2026
- 200 Pages
Middle East
From €2717EUR$2,990USD£2,335GBP
- Report
- March 2026
- 120 Pages
United States
From €3589EUR$3,950USD£3,085GBP
- Report
- November 2025
- 150 Pages
Middle East
From €5406EUR$5,950USD£4,647GBP
- Report
- November 2025
- 130 Pages
Middle East
From €5406EUR$5,950USD£4,647GBP
- Report
- November 2025
- 120 Pages
Middle East
From €5406EUR$5,950USD£4,647GBP
- Report
- November 2025
- 150 Pages
Middle East
From €5406EUR$5,950USD£4,647GBP
- Report
- October 2025
- 150 Pages
United States
From €5406EUR$5,950USD£4,647GBP
- Report
- October 2025
- 60 Pages
Asia Pacific
From €2953EUR$3,250USD£2,538GBP
- Report
- October 2025
- 64 Pages
Europe
From €2953EUR$3,250USD£2,538GBP
- Report
- July 2026
- 111 Pages
United States
From €4316EUR$4,750USD£3,710GBP
- Report
- June 2026
- 180 Pages
United States
From €4316EUR$4,750USD£3,710GBP
- Report
- December 2025
- 150 Pages
United States
From €4407EUR$4,850USD£3,788GBP
- Report
- December 2025
- 150 Pages
United States
From €4407EUR$4,850USD£3,788GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more